跳至主要内容
临床试验/IRCT20200719048133N1
IRCT20200719048133N1尚未招募4 期

?Efficacy of Varenicline for smoking cessation among persistent smokers after coronary artery revascularization: A randomized placebo controlled clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 600 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Male

入选标准

  • Male sex = 18 years old
  • Current daily smoker of = 5 cigarettes per day
  • Having a history of revascularization procedure for CAD in Tehran Heart 9-12 months prior to the study
  • Able to consent to the study and to follow its instructions and procedures

排除标准

  • Unstable cardiac disease
  • Known case of dementia disorders such as Alzheimer
  • Known case of chronic renal failure
  • Known or suspected unstable psychiatric disorders that require acute medical treatment
  • Only one member of a household is permitted to participate in the trial concurrently to minimize cohort-confounding effects

研究者

相似试验